889P Development of a head and neck immune prognostic index (HN-IPI) classification for patients with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) who received immune checkpoint inhibitors (ICIs)
Abstract
ICIs have demonstrated improved median overall survival (mOS) in patients with R/M HNSCC despite low response rates. Early Identification of patients that will derive benefit would be of high clinical utility. A strong rationale suggests a prognostic role for inflammatory biomarkers for...
Paper Details
Title
889P Development of a head and neck immune prognostic index (HN-IPI) classification for patients with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) who received immune checkpoint inhibitors (ICIs)
Published Date
Sep 1, 2021
Journal
Volume
32
Pages
S798 - S798
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History